403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Trump Announces Resignation of FDA Chief Makary
(MENAFN) U.S. President Donald Trump announced Tuesday that Food and Drug Administration (FDA) Commissioner Marty Makary has stepped down, with Kyle Diamantas immediately stepping in as the agency's acting head.
Trump broke the news via his Truth Social platform, offering a warm farewell to the departing commissioner. "I want to thank Dr. Marty Makary for having done a great job at the FDA," Trump said in a post on Truth Social. "So much was accomplished under his leadership. He was a hard worker, who was respected by all, and will go on to have an outstanding career in Medicine."
The president moved swiftly to name a successor. "Kyle Diamantas, a very talented person, will be put in the Acting position," Trump added.
Diamantas, a veteran of the agency, currently serves as the FDA's deputy commissioner for food. In that capacity, he oversees the agency's Human Foods Program, directing its nutrition and food safety operations nationwide.
Makary's exit follows weeks of mounting pressure, amid reported friction between senior White House and health officials and growing scrutiny surrounding a series of FDA regulatory decisions.
No timeline has been given for a permanent appointment.
Trump broke the news via his Truth Social platform, offering a warm farewell to the departing commissioner. "I want to thank Dr. Marty Makary for having done a great job at the FDA," Trump said in a post on Truth Social. "So much was accomplished under his leadership. He was a hard worker, who was respected by all, and will go on to have an outstanding career in Medicine."
The president moved swiftly to name a successor. "Kyle Diamantas, a very talented person, will be put in the Acting position," Trump added.
Diamantas, a veteran of the agency, currently serves as the FDA's deputy commissioner for food. In that capacity, he oversees the agency's Human Foods Program, directing its nutrition and food safety operations nationwide.
Makary's exit follows weeks of mounting pressure, amid reported friction between senior White House and health officials and growing scrutiny surrounding a series of FDA regulatory decisions.
No timeline has been given for a permanent appointment.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment